Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00897923 · ClinicalTrials.gov registry record
Imaging of Radiolabeled White Blood Cells in Patients With Non-Hodgkin's Lymphoma
A clinical trial, sponsored by Mayo Clinic.
- Completed
- Registry status
- 17
- Enrollment target
NCT00897923: Completed study, sponsored by Mayo Clinic.
NCT00897923 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 17 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00897923 has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 17 participants
- Enrollment target
Study Summary
RATIONALE: Measuring the number of radiolabeled white blood cells in non-Hodgkin's lymphoma tumors may help doctors predict how well patients will respond to treatment, and may help the study of cancer in the future. PURPOSE: This study is measuring radiolabeled white blood cells in patients with non-Hodgkin's lymphoma.
Interventions
- PROCEDURE radionuclide imaging
- RADIATION indium In 111-labeled autologous peripheral blood mononuclear cells
- RADIATION indium In 111-labeled autologous polymorphonuclear leukocytes
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2003-09 |
| Est. Completion | 2012-02-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00897923
The ClinicalTrials.gov registry entry for NCT00897923 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 17 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which radionuclide imaging is the first listed.
NCT00897923 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00897923 about?
NCT00897923 is a clinical study titled "Imaging of Radiolabeled White Blood Cells in Patients With Non-Hodgkin's Lymphoma". RATIONALE: Measuring the number of radiolabeled white blood cells in non-Hodgkin's lymphoma tumors may help doctors predict how well patients will respond to treatment, and may help the study of cancer in the future. PURPOSE: This study is measuring radiolabeled white blood cells in patients with n...
What is the current status of trial NCT00897923?
This trial is currently completed. The enrollment target is 17 participants. The study started on 2003-09. Estimated completion is 2012-02-10.
What interventions are being tested in trial NCT00897923?
The interventions under investigation include: radionuclide imaging (PROCEDURE), indium In 111-labeled autologous peripheral blood mononuclear cells (RADIATION), indium In 111-labeled autologous polymorphonuclear leukocytes (RADIATION).
Who is sponsoring clinical trial NCT00897923?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.